Methods and Kits for Volumetric Distribution of Pharmaceutical Agents via the Vascular Adventitia and Microcirculation
First Claim
Patent Images
1. A catheter comprising:
- a catheter body;
a needle having an aperture and being deployable from the catheter body to advance beyond an external elastic lamina (EEL) of a blood vessel wall and into adventitial tissue surrounding a lumen of the blood vessel; and
means coupled to the needle for detecting when the aperture of the needle has advanced beyond the EEL.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods and kits for delivering pharmaceutical agents to the adventitia and other regions outside the external elastic lamina (EEL) surrounding a blood vessel utilize a catheter having a needle. The needle is positioned in up to 5 mm beyond the EEL and delivers an amount of pharmaceutical agent sufficient to circumferentially permeate around the blood vessel and, in many cases, extend longitudinally and radially along the blood vessel. Confirmation that a delivery aperture of the needle lies beyond the EEL may be required before delivering the pharmaceutical agent.
-
Citations
23 Claims
-
1. A catheter comprising:
-
a catheter body; a needle having an aperture and being deployable from the catheter body to advance beyond an external elastic lamina (EEL) of a blood vessel wall and into adventitial tissue surrounding a lumen of the blood vessel; and means coupled to the needle for detecting when the aperture of the needle has advanced beyond the EEL. - View Dependent Claims (2, 3)
-
-
4. A kit for delivering a pharmaceutical agent to a patient suffering from or at risk of vascular disease, said kit comprising:
-
a catheter having a needle which can be advanced from a blood vessel lumen through a wall of the blood vessel to position an aperture of the needle beyond an external elastic lamina (EEL) of the wall by a distance not exceeding 5 mm; and instructions for use setting forth a method comprising; positioning the needle through the wall so that the aperture of the needle is positioned beyond the EEL by a distance not exceeding 5 mm; confirming that placement of the aperture is beyond the EEL and is in adventitial tissue surrounding the blood vessel lumen; and delivering an amount of the pharmaceutical agent from the aperture so that the agent distributes both longitudinally and radially from the injection site. - View Dependent Claims (5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)
-
Specification